Table 4.

Results of ABMT in Childhood AML in CR

Institution No. of PatientsStatus at Transplant Pretransplant RegimenPurging Actuarial Incidence of (at months) Comment Reference
LFS Relapse
CCG 2861  58  CR1  BU-CY  4 HC  51 (36)  42 Similar to allo-BMT  32  
Parkville, Australia  24  CR1 HDM  No  87 (60)  26   50  
Italian registry  110  CR1  All regimens TBI TBI/HDM No TBI     No Yes  41.4 78.8 85 27.2 (84)  45  TBI superior  65  
 48  CR2    41.5 (84)  44 All regimens equivalent 
EBMT-Pediatric  140 70  CR1 CR2  All regimens combined  No  46 36 (92)   No difference with allo-BMT TBI better for ABMT 66 
Institution No. of PatientsStatus at Transplant Pretransplant RegimenPurging Actuarial Incidence of (at months) Comment Reference
LFS Relapse
CCG 2861  58  CR1  BU-CY  4 HC  51 (36)  42 Similar to allo-BMT  32  
Parkville, Australia  24  CR1 HDM  No  87 (60)  26   50  
Italian registry  110  CR1  All regimens TBI TBI/HDM No TBI     No Yes  41.4 78.8 85 27.2 (84)  45  TBI superior  65  
 48  CR2    41.5 (84)  44 All regimens equivalent 
EBMT-Pediatric  140 70  CR1 CR2  All regimens combined  No  46 36 (92)   No difference with allo-BMT TBI better for ABMT 66 

Abbreviations: HDM, high-dose melphalan; 4HC, 4 hydroperoxycyclophosphamide; LFS, leukemia-free survival.

Close Modal

or Create an Account

Close Modal
Close Modal